Cargando…
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer
SIMPLE SUMMARY: Magnetic resonance imaging is commonly used in pre-treatment prostate cancer diagnostics. The assessment includes a five-stage scale classification called Prostate Imaging-Reporting and Data System (PI-RADS), routinely used to describe the probability of finding a clinically signific...
Autores principales: | Miszczyk, Marcin, Rembak-Szynkiewicz, Justyna, Magrowski, Łukasz, Stawiski, Konrad, Namysł-Kaletka, Agnieszka, Napieralska, Aleksandra, Kraszkiewicz, Małgorzata, Woźniak, Grzegorz, Stąpór-Fudzińska, Małgorzata, Głowacki, Grzegorz, Pradere, Benjamin, Laukhtina, Ekaterina, Rajwa, Paweł, Majewski, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997034/ https://www.ncbi.nlm.nih.gov/pubmed/35406385 http://dx.doi.org/10.3390/cancers14071613 |
Ejemplares similares
-
CyberKnife-based prostate cancer patient radioablation – early results of irradiation in 200 patients
por: Miszczyk, Leszek, et al.
Publicado: (2015) -
Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients
por: Miszczyk, Leszek, et al.
Publicado: (2017) -
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk
por: Miszczyk, Marcin, et al.
Publicado: (2022) -
Stereotactic Ablative Radiotherapy for Prostate Cancer—The Treatment Results
of 500 Patients and Analysis of Failures
por: Miszczyk, Leszek, et al.
Publicado: (2019) -
The Effectiveness and Toxicity of Frameless CyberKnife Based Radiosurgery for Parkinson’s Disease—Phase II Study
por: Goc, Bartłomiej, et al.
Publicado: (2023)